Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析

◆英語タイトル:Clearside BioMedical Inc (CLSD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME378786FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO – Retinal Vein Occlusion and DME – Diabetic Macular Edema and wet age related macular degeneration (wet AMD). Clearside’s proprietary suprachoroidal treatment approach offers unprecedented access to the back of the eye where sight threatening disease often occurs. The company also offers services such as business development, license agreements and contract manufacturing services. It markets its products across the US. Clearside is headquartered in Alpharetta, Georgia, the US.

Clearside BioMedical Inc Key Recent Developments

Apr 05,2021: Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit
Mar 10,2021: Clearside Biomedical Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Feb 24,2021: Clearside Biomedical to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update on Wednesday, March 10, 2021
Nov 10,2020: Clearside Biomedical announces third quarter 2020 financial results and provides corporate update
Sep 23,2020: Clearside Biomedical announces clinical data presentations at The Retina Society 2020 and publication of XIPERE data in diabetic macular edema in Ophthalmology Retina

This comprehensive SWOT profile of Clearside BioMedical Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Clearside BioMedical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Clearside BioMedical Inc – Key Information
Clearside BioMedical Inc – Overview
Clearside BioMedical Inc – Key Employees
Clearside BioMedical Inc – Key Employee Biographies
Clearside BioMedical Inc – Key Operational Heads
Clearside BioMedical Inc – Major Products and Services
Clearside BioMedical Inc – History
Clearside BioMedical Inc – Company Statement
Clearside BioMedical Inc – Locations And Subsidiaries
Clearside BioMedical Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Clearside BioMedical Inc – Business Description
Clearside BioMedical Inc – Corporate Strategy
Clearside BioMedical Inc – SWOT Analysis
SWOT Analysis – Overview
Clearside BioMedical Inc – Strengths
Clearside BioMedical Inc – Weaknesses
Clearside BioMedical Inc – Opportunities
Clearside BioMedical Inc – Threats
Clearside BioMedical Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Clearside BioMedical Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Clearside BioMedical Inc, Key Information
Clearside BioMedical Inc, Key Ratios
Clearside BioMedical Inc, Share Data
Clearside BioMedical Inc, Major Products and Services
Clearside BioMedical Inc, History
Clearside BioMedical Inc, Key Employees
Clearside BioMedical Inc, Key Employee Biographies
Clearside BioMedical Inc, Key Operational Heads
Clearside BioMedical Inc, Other Locations
Clearside BioMedical Inc, Subsidiaries
Clearside BioMedical Inc, Key Competitors
Clearside BioMedical Inc, SWOT Analysis
Clearside BioMedical Inc, Ratios based on current share price
Clearside BioMedical Inc, Annual Ratios
Clearside BioMedical Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arla Foods UK Plc:企業の戦略・SWOT・財務情報
    Arla Foods UK Plc - Strategy, SWOT and Corporate Finance Report Summary Arla Foods UK Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Edison International:企業の戦略・SWOT・財務情報
    Edison International - Strategy, SWOT and Corporate Finance Report Summary Edison International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • L’Oreal USA Inc:企業の戦略的SWOT分析
    L'Oreal USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Albemarle Corporation:企業の戦略・SWOT・財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oncolytics Biotech Inc (ONC):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • Advanced Accelerator Applications SA:医療機器:M&Aディール及び事業提携情報
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Pure Technologies Ltd:企業の戦略的SWOT分析
    Pure Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Netsmart Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Netsmart Technologies Inc (Netsmart) is a subsidiary of GI Partner, is a provider of enterprise software solutions for health and human services providers and payers. It provides on-demand and on-premise software solutions to automate major financial, clinical and management processes to its …
  • GATT Technologies BV:企業の製品パイプライン分析2018
    Summary GATT Technologies BV (GATT Technologies) is a medical technology company which develops synthetic surgical hemostat and sealant products that control severe bleeding. Its product pipeline includes GATT-Patch for controlling excessive bleeding; GATT-Tape for blocking intestinal anastomotic le …
  • One Way Liver SL-製薬・医療分野:企業M&A・提携分析
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that discovers, develops and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver, which is a serum based test used for steatosis and NASH diagn …
  • Titan Cement Company Sa:企業の戦略・SWOT・財務分析
    Titan Cement Company Sa - Strategy, SWOT and Corporate Finance Report Summary Titan Cement Company Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vienna Insurance Group AG:企業の戦略・SWOT・財務情報
    Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report Summary Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • United Technologies Corporation:企業の戦略・SWOT・財務情報
    United Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary United Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Magellan Aerospace Corp:企業の戦略・SWOT・財務情報
    Magellan Aerospace Corp - Strategy, SWOT and Corporate Finance Report Summary Magellan Aerospace Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Yatra Online, Inc. (YTRA):企業の財務・戦略的SWOT分析
    Yatra Online, Inc. (YTRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Canadian Natural Resources Ltd (CNQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing and sale of crude oil, natural gas and natural gas liquids (NGLs). Canadian Natural’s products include light …
  • Cree Inc (CREE):電力:M&Aディール及び事業提携情報
    Summary Cree, Inc (Cree) is a provider of semiconductor and lighting products for radio-frequency (RF) and power applications. The company’s product portfolio includes LED chips, LED components and LED lighting solutions and SiC and GaN materials and products. It also offers power and radio frequenc …
  • UniQuest Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • Bank Of Panhsin
    Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆